Jacobs Levy Equity Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
218,779
-519,176
| -70% | -$2.66M | ﹤0.01% | 737 |
|
|
2025
Q1 | $1.01M | Buy |
737,955
+220,529
| +43% | +$302K | ﹤0.01% | 807 |
|
|
2024
Q4 | $1.6M | Buy |
+517,426
| New | +$1.6M | 0.01% | 642 |
|
|
2024
Q2 | – | Sell |
-21,338
| Closed | -$169K | – | 1041 |
|
|
2024
Q1 | $169K | Sell |
21,338
-34,476
| -62% | -$274K | ﹤0.01% | 900 |
|
|
2023
Q4 | $553K | Sell |
55,814
-87,667
| -61% | -$868K | ﹤0.01% | 815 |
|
|
2023
Q3 | $1.62M | Sell |
143,481
-175,295
| -55% | -$1.97M | 0.01% | 598 |
|
|
2023
Q2 | $1.06M | Sell |
318,776
-86,789
| -21% | -$288K | 0.01% | 691 |
|
|
2023
Q1 | $1.6M | Buy |
405,565
+59,094
| +17% | +$233K | 0.01% | 613 |
|
|
2022
Q4 | $2.51M | Buy |
346,471
+548
| +0.2% | +$3.97K | 0.02% | 510 |
|
|
2022
Q3 | $1.25M | Buy |
+345,923
| New | +$1.25M | 0.01% | 660 |
|